PSA demands equity of healthcare access for Aboriginal and Torres Strait...

From changes to policy, service design and delivery, PSA calls for action to improve Aboriginal and Torres Strait Islander healthcare.

COVID-19 healthcare leader moves into new role

Deputy Chief Medical Officer Professor Michael Kidd AO reflects on steering Australia through the COVID-19 pandemic and his next career move.

Why you should read PSA’s new medicine management guidelines

At PSA22, new guidelines were launched to help pharmacists support Aboriginal and Torres Strait Islander peoples with Medicines Management. 

The aged care researcher

The expert witness testimony of Dr Janet Sluggett MPS at the aged care royal commission last year resulted in changes to the RMMR program.

COVID-19: Finish line or first lap?

As Australia reaches vaccine targets, what’s next for pharmacists and Australians?

Amitriptyline for irritable bowel syndrome

Ordinarily used to treat other conditions, this trycylic antidepressant performed well in a recent trial on people with IBS. Irritable bowel syndrome (IBS) is estimated...